Cypherpunk Technologies (CYPH)
Builds a Zcash treasury and privacy technologies while retaining an oncology subsidiary.
$1.76
Pre-market+0.09 (+5.16%)
At close$1.68(−2.05%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 6 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | −6 | 0 | 0 | 0 | −10 | 0 | 0 | 0 | 0 | 0 | 0 |
| 15 | 6 | 15 | 21 | 18 | 35 | 16 | 17 | 3 | 5 | 5 | 5 | |
| Research & development | 12 | 7 | 11 | 18 | 15 | 13 | 13 | 11 | 1 | 1 | 0 | 0 |
| 3 | 5 | 4 | 3 | 3 | 8 | 3 | 2 | 2 | −2 | 5 | 4 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 3 | 5 | 4 | 3 | 3 | 7 | 3 | 2 | 2 | −2 | 5 | 4 |
| Other expenses | 0 | −6 | 0 | 0 | 0 | 13 | 0 | 5 | 0 | 6 | 0 | 0 |
| Operating income | −15 | −12 | −15 | −21 | −18 | −45 | −16 | −17 | −3 | −5 | −5 | −5 |
| 1 | 0 | 1 | 1 | 0 | 3 | 0 | 0 | 0 | 50 | −77 | 46 | |
| Interest income | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −1 | 0 | −1 | 0 | 0 | −24 | 0 | 0 | 0 | −50 | 77 | 0 |
| Income before tax | −14 | −12 | −14 | −20 | −17 | −42 | −15 | −17 | −3 | 45 | −82 | 41 |
| Income tax expense | 0 | 8 | 0 | 0 | 1 | −2 | 0 | 0 | 0 | 5 | −5 | 2 |
| Net income from continuing operations | −14 | −19 | −14 | −20 | −18 | −40 | −15 | −17 | −3 | 40 | −77 | 39 |
| Discontinued operations | 0 | −5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −14 | −25 | −14 | −20 | −18 | −40 | −15 | −17 | −3 | 40 | −77 | 39 |
| EPS, basic | −$0.51 | −$0.46 | −$0.51 | −$0.51 | −$0.44 | −$0.37 | −$0.37 | −$0.40 | −$0.08 | $0.92 | −$0.46 | $0.21 |
| EPS, diluted | −$0.51 | −$0.46 | −$0.51 | −$0.51 | −$0.44 | −$0.37 | −$0.37 | −$0.40 | −$0.08 | $0.92 | −$0.46 | $0.25 |
| Weighted average shares, basic | 27 | 27 | 27 | 39 | 41 | 41 | 41 | 41 | 41 | 66 | 168 | 176 |
| Weighted average shares, diluted | 27 | 27 | 27 | 39 | 41 | 41 | 41 | 41 | 41 | 71 | 168 | 176 |
| EBITDA | −14 | −11 | −14 | −21 | −18 | −20 | −15 | −17 | −3 | 45 | −82 | −5 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −14 | −12 | −14 | −21 | −18 | −21 | −15 | −17 | −3 | 45 | −82 | −5 |
